Expedition Medicines
1 known investors
Find your way into Expedition Medicines
Sign up to see every warm intro you have to Expedition Medicines
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Expedition Medicines team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Expedition Medicines is a drug discovery company developing small-molecule covalent medicines for targets considered 'undruggable', using proprietary proteomic data, AI, and quantum chemistry to design molecules that bind previously inaccessible protein surfaces. Its pipeline includes first-in-class programs in oncology, immunology, and other diseases.
Founders & leadership
AR
Alec ReynoldsPresident & Chief Executive Officer
Investors · 1
Frequently asked questions
- What does Expedition Medicines do?
- Expedition Medicines is a drug discovery company developing small-molecule covalent medicines for targets considered 'undruggable', using proprietary proteomic data, AI, and quantum chemistry to design molecules that bind previously inaccessible protein surfaces. Its pipeline includes first-in-class programs in oncology, immunology, and other diseases.
- Who are Expedition Medicines's investors?
- Expedition Medicines's investors include Flagship Pioneering.
